Back to list


University of North Carolina at Chapel Hill


Many people experiencing urine leakage are not satisfied with their current treatments. The CONTENT clinical research trial is currently evaluating an investigational drug for its effectiveness on urine leakage in patients with Multiple Sclerosis (MS) or who have a spinal cord injury.


Brain/Head, Men's Health, Urinary, Women's Health


Drug or Biologic



18 - 80 years


Study Population

Adults - MS or Spinal Cord Injury Incontinence


Kristy Borawski
Clinical Associate Professor
Urology - Clinic

For questions, contact:

Chris Paterno
(919) 537-3505
Visit Website

Recruitment Period End

December 31, 2018


Primary Location
UNC Urology Clinic
101 Manning Dr #2, Chapel Hill, NC 27514, USA

Study Qualifications

Gender Any

Age Range 18 - 80 years

Participant qualification(s) Bladder overactivity at least 3 months resulting from Spinal Cord Injury or MS, Routine catherization every 4-6 hours while awake or more frequently

Not eligible if: Any condition other than bladder overactivity that impacts bladder function, Any surgical procedure within 6 month that involved the bladder

Number of Visits

    » 14 In person visit(s)

    2 Screening, 12 Clinic

    » 8 Remote visit(s)

    8 Phone

Participation Period

24 months


$50 per visit

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.